tesaglitazar protective_against triglycerides
Evidence from:
primary |
all sources
Evidence (1 sources)
The PPAR α / γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat.
(2013)
PMID:24285952
cited
This dose gives a close to maximal ... triglyceride lowering in ob/ob mice.
confidence: 0.90